Navidea Biopharmaceuticals (NAVB) News Today $0.0010 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 19, 2024 | americanbankingnews.comNavidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated by Analysts at StockNews.comJuly 3, 2024 | businesswire.comNavidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024June 20, 2024 | businesswire.comNavidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024May 25, 2024 | wsj.comSK Biopharmaceuticals Co. Ltd.May 3, 2024 | nasdaq.comDay One Biopharmaceuticals, Inc. Common Stock (DAWN)February 23, 2024 | benzinga.comNavidea Biopharmaceutical Stock (OTC:NAVB), Short Interest ReportFebruary 22, 2024 | benzinga.comNavidea Biopharmaceutical Stock (OTC:NAVB) Dividends: History, Yield and DatesFebruary 22, 2024 | benzinga.comNavidea Biopharmaceutical Stock (OTC:NAVB) Insider TradesJanuary 29, 2024 | bizjournals.comCentral Ohio public company voluntarily deregisters stockJanuary 26, 2024 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting ObligationsJanuary 26, 2024 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting ObligationsJanuary 11, 2024 | investing.comSuzhou Zelgen Biopharmaceuticals Co Ltd (688266)December 1, 2023 | msn.comNavidea settles litigation with Capital Royalty, stock rallies 30%December 1, 2023 | markets.businessinsider.comNavidea Biopharmaceuticals, CRG Settle All Ongoing LitigationNovember 1, 2023 | morningstar.comNavidea Biopharmaceuticals Inc NAVBOctober 26, 2023 | investing.comNavidea Biopharmaceuticals faces delisting from NYSE American, plans to move to OTC marketsOctober 6, 2023 | bizjournals.comNYSE American halts trading on Navidea stock after delisting recommendedOctober 5, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common StockOctober 5, 2023 | tmcnet.comNYSE American to Suspend Trading in Navidea Biopharmaceuticals, Inc. (NAVB)August 10, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing PanelAugust 1, 2023 | finance.yahoo.comNYSE American starts to delist Navidea stock, company to appealJuly 31, 2023 | benzinga.comWhy Navidea Biopharmaceuticals Shares Are NosedivingJuly 31, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Presses Ahead, Embraces OpportunitiesJuly 28, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American DeterminationJuly 28, 2023 | businesswire.comNYSE American to Commence Delisting Proceedings Against Navidea Biopharmaceuticals, Inc. (NAVB)July 28, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial OfficerJuly 13, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps DownJuly 6, 2023 | bizjournals.comDublin biotech proposes reverse stock split, stock-for-debt swapJune 30, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain AssetsJune 16, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Announces Distribution of Series K Preferred Stock to Holders of its Common StockJune 16, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone PaymentJune 7, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Reports First Quarter 2023 Financial Results and Provides Business UpdateJune 2, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Receives NYSE American NoticeMay 22, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Investors Purchase $1.1 Million in Preferred Shares at MarketMay 15, 2023 | investing.comNavidea Biopharma (NAVB) Earnings Dates & ReportsMay 11, 2023 | msn.comNavidea promotes Michael Sherman Blue to CMO postMay 8, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Drives Strategy Forward, Shifts Approach for CommunicationsApril 27, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of CreditApril 13, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694March 30, 2023 | businesswire.comNavidea Biopharmaceuticals, Inc. Hires G2G Ventures as Executive Consultants; Chief Medical Officer Steps DownMarch 24, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. (AMEX:NAVB) Q4 2022 Earnings Call TranscriptMarch 22, 2023 | finance.yahoo.comQ4 2022 Navidea Biopharmaceuticals Inc Earnings CallMarch 21, 2023 | finance.yahoo.comNavidea Biopharmaceuticals Reports Fourth Quarter 2022 Financial ResultsMarch 15, 2023 | finance.yahoo.comNavidea Biopharmaceuticals to Host Fourth Quarter 2022 Earnings Conference Call and Business UpdateJanuary 24, 2023 | reuters.comNAVB.PH - | Stock Price & Latest News | ReutersJanuary 3, 2023 | msn.comNavidea stock soars ~25% on upcoming US patent linked to cancer drug pipelineJanuary 3, 2023 | finance.yahoo.comNavidea Biopharmaceuticals Announces the Notice of Allowance for U.S. Patent Application for Key Component of the Company’s Cancer Immunotherapy PipelineDecember 28, 2022 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. (AMEX:NAVB) Q3 2022 Earnings Call TranscriptNovember 30, 2022 | finance.yahoo.comNavidea Biopharmaceuticals Files Appeal in CRG CaseNovember 28, 2022 | finance.yahoo.comNavidea Biopharmaceuticals Announces 50th Participant Enrolled in the Company’s Phase 3 Trial in Rheumatoid Arthritis Get Navidea Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NAVB and its competitors with MarketBeat's FREE daily newsletter. Email Address “Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event. You can find out what they are by clicking here now. NAVB Media Mentions By Week NAVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NAVB News Sentiment▼0.000.62▲Average Medical News Sentiment NAVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NAVB Articles This Week▼00▲NAVB Articles Average Week Get Navidea Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NAVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IDEXX Laboratories News Today Lantheus News Today Neogen News Today Intellia Therapeutics News Today Celldex Therapeutics News Today Myriad Genetics News Today QuidelOrtho News Today Achieve Life Sciences News Today Alpha Teknova News Today VolitionRx News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NAVB) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Navidea Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Navidea Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
